Ending drug shortages with synthetic biology
Nature is our most powerful source of medicine
Nature is our most powerful source of medicine
While nature has provided the foundation for modern medicine, it wasn’t designed to meet the scale and demand of 21st century healthcare needs.
Today’s pharmaceutical supply chains are largely reliant on fragile agricultural sources with low predictability, resulting in drug shortages that ultimately impact patient care.
We manufacture essential medicines
Antheia leverages synthetic biology to produce biosynthetic Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines in a more efficient, agile, and sustainable approach. Our platform enables resilient and scalable pharmaceutical supply chains, domestic and rapid-response manufacturing, and more equitable channels of distribution. Synthetic biology has the potential to transform supply chains and unlock new opportunities in drug development and discovery.
A revolutionary alternative to legacy approaches
The USDA cites that 40% of Western drugs are derived from plants. These medicines are sourced in an agricultural process that is typically inefficient, inflexible, and highly susceptible to climate events, inconsistent soil health, pests, and diseases. We need a more efficient, sustainable, and reliable approach than legacy agricultural-based sources.
Supply Chain
Agricultural sources can have unpredictable yields. Manufacturing in contained fermentation environments offers a more reliable, controlled, and consistent supply.
Resource Utilization
Agricultural-based manufacturing is inefficient and expensive. Purpose-built biomanufacturing facilities reduce the need for agricultural sourcing and the associated costs, environmental impacts, and long timelines.
Novel Solution
Chemical synthesis is not suitable for KSMs and APIs of greater complexity. Synthetic biology – the most advanced 21st century technology – enables efficient biomanufacturing of pharma ingredients of unprecedented complexity.
Setting a new standard for pharma manufacturing
Efficiency
Reduced timelines from years to weeks
Speed
Reduced timelines from years to weeks
Sustainability
Reduced environmental footprint
Agility
On-demand and low-latency capabilities
Reliability
Predictable and consistent yields
Innovation
Revolutionary approach to pharma manufacturing
Fortifying pharmaceutical supply chains is urgent
+2 billion people worldwide
lack access to basic medicines.
- World Health Organization
~78% of API manufacturers are
located outside of the U.S.
- FDA
Up to 50 new drug shortages per year for the last decade.
- FDA / Brookings Institute
1.5 years is the average duration
of a drug shortage.
- Homeland Security & Government Affairs Committee report
Engineering the most complex biosynthesis pathways in yeast
Our biomanufacturing platform enables efficient, reliable, and at-scale commercial manufacturing for pharmaceutical products.
We manufacture essential medicines
Antheia leverages synthetic biology to produce biosynthetic Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines in a more efficient, agile, and sustainable approach. Our platform enables resilient and scalable pharmaceutical supply chains, domestic and rapid-response manufacturing, and more equitable access to critical medicines. Synthetic biology will transform pharmaceutical supply chains and has the potential to unlock new opportunities in drug development and discovery.
A revolutionary alternative to legacy approaches
The USDA cites that 40% of Western drugs are derived from plants. These medicines are sourced in an agricultural process that is typically inefficient, inflexible, and highly susceptible to climate events, inconsistent soil health, pests, and diseases. We need a more efficient, sustainable, and reliable approach than legacy agricultural-based sources.
Supply chain
Agricultural sources can have unpredictable yields. Manufacturing in contained fermentation environments offers a more reliable, controlled, and consistent supply.
Resource utilization
Agricultural-based manufacturing is inefficient and expensive. Purpose-built biomanufacturing facilities reduce the need for agricultural sourcing and the associated costs, environmental impacts, and long timelines.
Novel solution
Chemical synthesis is not suitable for KSMs and APIs of greater complexity. Synthetic biology – the most advanced 21st century technology – enables efficient biomanufacturing of pharma ingredients of unprecedented complexity.
Fortifying pharmaceutical supply chains is urgent
+2 billion people worldwide
lack access to basic medicines.
- World Health Organization
~78% of API manufacturers are
located outside of the U.S.
- FDA
Up to 50 new drug shortages per year for the last decade.
- FDA / Brookings Institute
1.5 years is the average duration
of a drug shortage.
- Homeland Security & Government Affairs Committee report
Engineering the most complex biosynthesis pathways in yeast
Our biomanufacturing platform enables efficient, reliable, and at-scale commercial manufacturing for pharmaceutical products.
Setting a new standard for pharma manufacturing
Efficiency
Reduced costs and optimized resources
Speed
Agility
Reliability
Sustainability
Innovation
Engineering the most complex biosynthesis pathways in yeast
Our biomanufacturing platform enables efficient, reliable, and at-scale commercial manufacturing for pharmaceutical products.
Antheia in the news
Industry News
Industry News
Industry News
Industry News
Industry News
Industry News
Tes
The pandemic has exposed our broken pharma supply chain. Synthetic biology and brewer’s yeast could fix it
Short description of the article that should be one sentence and no longer than the text used in this example right here for you to see. (That's 30 words total)
Read more
News
The pandemic has exposed our broken pharma supply chain. Synthetic biology and brewer’s yeast could fix it
Short description of the article that should be one sentence and no longer than the text used in this example right here for you to see. (That's 30 words total)
Read more
Ambient
Work
News
The pandemic has exposed our broken pharma supply chain. Synthetic biology and brewer’s yeast could fix it
Short description of the article that should be one sentence and no longer than the text used in this example right here for you to see. (That's 30 words total)
Read more
News
The pandemic has exposed our broken pharma supply chain. Synthetic biology and brewer’s yeast could fix it
Short description of the article that should be one sentence and no longer than the text used in this example right here for you to see. (That's 30 words total)